Medicinal products containing the active substance apalutamide 2026
Léčivé přípravky s obsahem účinné látky apalutamid 2026
Czechia · Plzeň · how to bid here →
Your path to submission
- Deadline: 14 October at 00:00 — 32 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: CES.
- Collect your evidence — the eligibility requirements are listed above; for many of them the analysis explains how to obtain them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every 1 months (454 awards, most recently June 2026) — by that rhythm the next award was due around July 2026. The last award went to BAXTER CZECH spol. s r.o..n = 454
- 38% of this buyer's awards went to companies that had already won here before (989 awards since 2015, spread over 194 companies). That is well below the sector norm (69%) — this buyer switches suppliers more often than others.n = 989 awards since 2015
- The median procedure drew 2 bids (809 procedures with a bid count); 38% ended with a single bidder. Sector: median 2 bids.n = 809
- The award came in at a median 94% of the estimated value (100 awards with both estimate and value) — pricing at the estimate is usually too high here. Sector: 98%.n = 100
- 13% of awards went to companies from abroad (989 awards with a known winner country). Sector average: 10%.n = 989
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 11/09/2026.
Foreign bidders
In Czechia · Medical equipment & pharma, 100 contracts went to foreign companies over the last 3 years (of 16,560 recorded awards) — mostly from Germany, Poland, Austria.
Typical field: median 3 (from 380 awards).
What the buyer is looking for
Předmětem veřejné zakázky jsou dodávky léčivých přípravků určených pro terapii hormon-senzitivního karcinomu prostaty v celkovém předpokládaném objemu 360 000 jednotlivých dávek léčivých přípravků. Přípravky jsou určeny pro poskytování zdravotní péče na zdravotnických pracovištích FN Plzeň. Dodávky předmětu plnění budou realizovány na základě výsledků ukončeného zadávacího řízení po dobu tří let od podpisu kupní smlouvy.
Selection criteria — in the procurement documents
The buyer states in the notice that the selection criteria are in the procurement documents (link on the right), not in the EU form. The document analysis below extracts them from there — bid and evidence in CES.
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| PHOENIX lékárenský velkoobchod, s.r.o. | 40 | 2022–2026 |
| Alliance Healthcare s.r.o. | 36 | 2015–2026 |
| PROMEDICA PRAHA GROUP, a.s. | 31 | 2022–2026 |
| Fresenius Kabi s.r.o. | 16 | 2015–2026 |
| PHARMOS, a.s. | 16 | 2022–2025 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.